Hepatoblastoma en el niño

作者: L. Brugières , S. Franchi-Abella , I. Aerts , S. Taque , B. Fresneau

DOI: 10.1016/S1245-1789(21)44718-9

关键词:

摘要: Resumen El hepatoblastoma es un tumor infrecuente del nino pequeno. Mas 90% de los casos se diagnostican en el menor 5 anos. Este aparece higado sano, ausencia cirrosis. Puede presentarse aislado o incluido marco sindrome predisposicion. Se sospecha rapidamente su diagnostico ante la asociacion hepatico y una concentracion plasmatica alfa-feto-proteina elevada. Las pruebas imagen permiten confirmar localizacion intrahepatica masa, descartar factores pronosticos locales, establecer operabilidad e identificar localizaciones secundarias. La patologia marcadores tisulares confirman criterios histologicos pronosticos. han identificado varias vias senalizacion implicadas no desarrollo higado, que solo considerar nuevos objetivos terapeuticos, sino tambien clasificacion hepatoblastomas. tratamiento asocia quimioterapia con platinos exeresis quirurgica tumor, algunos puede requerir trasplante hepatico. pronostico estos tumores bueno, supervivencia global cercana al 80% a 3 anos, mayor las formas riesgo estandar alto caracterizadas por presencia menos uno siguientes factores: metastasis, afectacion difusa normal alfa-feto-proteina, ruptura tumoral, invasion vascular edad superior igual 8 Sin embargo, toxicidad auditiva cisplatino sigue siendo importante efecto secundario. Por lo tanto, protocolo internacional PHITT (Pediatric Hepatic International Tumor Trial) recomienda desescalada terapeutica bajo riesgo.

参考文章(48)
Anne-Sophie Defachelles, Nathalie Rocourt, Sophie Branchereau, Michel Peuchmaur, Le pancréatoblastome chez l’enfant : du diagnostic à la prise en charge thérapeutique Bulletin Du Cancer. ,vol. 99, pp. 793- 799 ,(2012) , 10.1684/BDC.2012.1600
Jon Pritchard, Julia Brown, Elizabeth Shafford, Giorgio Perilongo, Penelope Brock, Claire Dicks-Mireaux, Jean Keeling, Angela Phillips, Anton Vos, Jack Plaschkes, Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma : A successful approach: Results of the first prospective study of the International Society of Pediatric Oncology Journal of Clinical Oncology. ,vol. 18, pp. 3819- 3828 ,(2000) , 10.1200/JCO.2000.18.22.3819
Noboru Kobayashi, Hitoshi Ikeda, Michio Kaneko, Mutsuro Ohira, Masako Tanimura, Masaru Yokoyama, Ichiro Matsui, Jun Abe, Increased Risk of Hepatoblastoma among Immature Children with a Lower Birth Weight Cancer Research. ,vol. 58, pp. 3032- 3035 ,(1998)
József Zsiros, Laurence Brugieres, Penelope Brock, Derek Roebuck, Rudolf Maibach, Arthur Zimmermann, Margaret Childs, Daniele Pariente, Veronique Laithier, Jean-Bernard Otte, Sophie Branchereau, Daniel Aronson, Arun Rangaswami, Milind Ronghe, Michela Casanova, Michael Sullivan, Bruce Morland, Piotr Czauderna, Giorgio Perilongo, Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study Lancet Oncology. ,vol. 14, pp. 834- 842 ,(2013) , 10.1016/S1470-2045(13)70272-9
Hiroaki Fukuzawa, Naoto Urushihara, Koji Fukumoto, Maki Mitsunaga, Kentaro Watanabe, Takeshi Aoba, Shinya Yamoto, Hiromu Miyake, Shiro Hasegawa, Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy? Pediatric Surgery International. ,vol. 28, pp. 887- 891 ,(2012) , 10.1007/S00383-012-3139-X
Janet I. Malowany, Neil H. Merritt, Nancy G. Chan, Bo-Yee Ngan, Nested stromal epithelial tumor of the liver in Beckwith-Wiedemann syndrome. Pediatric and Developmental Pathology. ,vol. 16, pp. 312- 317 ,(2013) , 10.2350/13-02-1300-CR.1
Jean-François Michiels, Paul Hofman, Francine Arbez-Gindre, Hélène Jouan, Marie-Christine Rousselet-Chapeau, Dominique Berrebi, Luc Marcellin, François Plenat, Dominique Zachar, Madeleine Joubert, Janick Selves, Dominique Pasquier, Paulette Bioulac-Sage, Michael Grotzer, Margaret Childs, Monique Fabre, Marie-Annick Buendia, Stefano Cairo, Carolina Armengol, Aurélien De Reyniès, Yu Wei, Emilie Thomas, Claire-Angélique Renard, Andrei Goga, Asha Balakrishnan, Michaela Semeraro, Lionel Gresh, Marco Pontoglio, Hélène Strick-Marchand, Florence Levillayer, Yann Nouet, David Rickman, Frédéric Gauthier, Sophie Branchereau, Laurence Brugières, Véronique Laithier, Raymonde Bouvier, Françoise Boman, Giuseppe Basso, Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer Cancer Cell. ,vol. 14, pp. 471- 484 ,(2008) , 10.1016/J.CCR.2008.11.002
Dolores López-Terrada, Rita Alaggio, Maria T de Dávila, Piotr Czauderna, Eiso Hiyama, Howard Katzenstein, Ivo Leuschner, Marcio Malogolowkin, Rebecka Meyers, Sarangarajan Ranganathan, Yukichi Tanaka, Gail Tomlinson, Monique Fabrè, Arthur Zimmermann, Milton J Finegold, Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium Modern Pathology. ,vol. 27, pp. 472- 491 ,(2014) , 10.1038/MODPATHOL.2013.80
Bassan J Allan, Punam P Parikh, Sofia Diaz, Eduardo A Perez, Holly L Neville, Juan E Sola, None, Predictors of survival and incidence of hepatoblastoma in the paediatric population Hpb. ,vol. 15, pp. 741- 746 ,(2013) , 10.1111/HPB.12112
Gerald Assmann, Roland Kappler, Evelyn Zeindl-Eberhart, Irene Schmid, Beate Häberle, Christian Graeb, Andreas Jung, Josef Müller-Höcker, β-Catenin mutations in 2 nested stromal epithelial tumors of the liver—a neoplasia with defective mesenchymal-epithelial transition Human Pathology. ,vol. 43, pp. 1815- 1827 ,(2012) , 10.1016/J.HUMPATH.2012.03.018